Cargando…
Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
Background: Long acting insulin detemir administered intranasally for three weeks enhanced memory for adults with Alzheimer’s disease dementia (AD) or amnestic mild cognitive impairment (MCI). The investigation of longer-term administration is necessary to determine whether benefits persist, whether...
Autores principales: | Craft, Suzanne, Claxton, Amy, Baker, Laura D., Hanson, Angela J., Cholerton, Brenna, Trittschuh, Emily H., Dahl, Deborah, Caulder, Erin, Neth, Bryan, Montine, Thomas J., Jung, Youngkyoo, Maldjian, Joseph, Whitlow, Christopher, Friedman, Seth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409050/ https://www.ncbi.nlm.nih.gov/pubmed/28372335 http://dx.doi.org/10.3233/JAD-161256 |
Ejemplares similares
-
Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach
por: Cholerton, Brenna, et al.
Publicado: (2016) -
Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial
por: Hoscheidt, Siobhan, et al.
Publicado: (2021) -
Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
por: Neth, Bryan J., et al.
Publicado: (2017) -
A nonhuman primate model of early Alzheimer’s disease pathologic change: Implications for disease pathogenesis
por: Latimer, Caitlin S., et al.
Publicado: (2018) -
Neural predictors of emotional inertia in daily life
por: Waugh, Christian E., et al.
Publicado: (2017)